Denali Therapeutics Inc (DNLI)
Healthcare
Biotechnology
23.00 $
-5.5%
vs. previous close
Closing price · As of: 31. Jul 2026
Denali Therapeutics Inc (DNLI) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -131 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -113 | -87 | -99 | -114 | -91 | -59 | -84 | -131 | -75 | -107 | -99 | -131 | -412 | |
| 1.4 | 2.2 | 2.2 | 2.2 | 1.9 | 1.8 | 1.9 | 3.2 | 3.0 | 2.9 | 3.8 | 3.8 | 14 | |
| 27 | 27 | 26 | 28 | 25 | 25 | 25 | 25 | 25 | 25 | 24 | 23 | 98 | |
| 27 | – | – | – | – | – | – | – | – | – | – | – | – | |
| -313 | -4.4 | 5.8 | -16 | -8.2 | 30 | 11 | -22 | 23 | -6.2 | 5.0 | -27 | -5.4 | |
| 5.9 | 2.1 | 2.2 | 2.2 | 4.8 | 3.9 | 5.1 | 5.1 | 4.3 | 1.4 | 1.5 | 2.5 | 9.6 | |
| 168 | 101 | 73 | -453 | 99 | 94 | 172 | 19 | 158 | 58 | 21 | 94 | 331 | |
| 9.0 | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | -24 | -8.3 | -4.4 | -2.4 | -1.4 | 0.0 | 0.0 | -3.8 | |
| 9.0 | 2.5 | 4.7 | 500 | 6.8 | -19 | -4.2 | -3.8 | 1.6 | -0.8 | 192 | 219 | 412 | |
| 64 | 16 | -21 | -67 | 14 | 16 | 84 | -116 | 84 | -50 | 114 | 182 | 331 | |
| -119 | -89 | -101 | -116 | -96 | -63 | -89 | -137 | -80 | -106 | -100 | -134 | -419 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.